{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:11:46Z","timestamp":1770822706405,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.humpath.2013.06.011","type":"journal-article","created":{"date-parts":[[2013,9,9]],"date-time":"2013-09-09T11:47:47Z","timestamp":1378727267000},"page":"2509-2517","source":"Crossref","is-referenced-by-count":4,"title":["Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions"],"prefix":"10.1016","volume":"44","author":[{"given":"Neda A.","family":"Moatamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Vergara-Lluri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia K.","family":"Apple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Kerkoutian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Yu","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2013.06.011_bb0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","article-title":"Cancer treatment and survivorship statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2013.06.011_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","article-title":"Cancer statistics, 1997","volume":"47","author":"Parker","year":"1997","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.humpath.2013.06.011_bb0015","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00000478-200108000-00013","article-title":"Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens","volume":"25","author":"McKenney","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0020","first-page":"2794","article-title":"Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder","volume":"37","author":"Farrow","year":"1977","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.06.011_bb0025","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0030","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.06.011_bb0035","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<355::AID-CNCR16>3.0.CO;2-Y","article-title":"Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma","volume":"82","author":"Klein","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.06.011_bb0040","first-page":"202","article-title":"Cytokeratin 20 as an immunocytochemical marker for detection of urothelial carcinoma in atypical cytology: preliminary retrospective study on archived urine slides","volume":"25","author":"Lin","year":"2001","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.humpath.2013.06.011_bb0045","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.5858\/2008-132-1648-PCIAHH","article-title":"ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy","volume":"132","author":"Siddiqui","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2013.06.011_bb0050","doi-asserted-by":"crossref","first-page":"918","DOI":"10.5858\/2008-132-918-LCEOAN","article-title":"Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens","volume":"132","author":"Tambouret","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2013.06.011_bb0055","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/PAS.0b013e3181e3291e","article-title":"A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas","volume":"34","author":"Kong","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0060","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/PAS.0b013e31815bbb69","article-title":"BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix","volume":"32","author":"Badr","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0065","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/modpathol.2008.101","article-title":"Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics","volume":"21","author":"Pinto","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0070","first-page":"157","article-title":"The role of deeper levels and ancillary studies (p16(Ink4a) and ProExC) in reducing the discordance rate of Papanicolaou findings of high-grade squamous intraepithelial lesion and follow-up cervical biopsies","volume":"117","author":"David","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.06.011_bb0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/modpathol.2008.171","article-title":"BD ProEx C immunostaining in extramammary Paget's disease and perineal melanoma","volume":"22","author":"Walts","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0080","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/PAS.0b013e3181ecf829","article-title":"Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A","volume":"34","author":"Chen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/PGP.0b013e3181ae81a0","article-title":"Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens","volume":"29","author":"Sanati","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1309\/AJCP1LLX8QMDXHHO","article-title":"Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma","volume":"135","author":"Guo","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/cncy.21264","article-title":"ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens","volume":"121","author":"Moatamed","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0100","series-title":"World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Urinary System and Male Genital Organs","first-page":"110","article-title":"Tumours of the urinary system. Non-invasive urothelial tumours","author":"Sauter","year":"2004"},{"key":"10.1016\/j.humpath.2013.06.011_bb0105","series-title":"Laboratory medicine. Test selection and interpretation","first-page":"1","article-title":"Principles of laboratory medicine","author":"Howanitz","year":"1991"},{"key":"10.1016\/j.humpath.2013.06.011_bb0110","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<625::AID-CNCR20>3.0.CO;2-A","article-title":"Flat intraepithelial lesions of the urinary bladder","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2013.06.011_bb0115","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/modpathol.3880241","article-title":"Relationship of cytokeratin 20 and CD44 protein expression with WHO\/ISUP grade in pTa and pT1 papillary urothelial neoplasia","volume":"13","author":"Desai","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00125480-200207000-00002","article-title":"An approach to the diagnosis of flat intraepithelial lesions of the urinary bladder using the World Health Organization\/International Society of Urological Pathology consensus classification system","volume":"9","author":"Amin","year":"2002","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.humpath.2009.07.002","article-title":"Urothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features","volume":"41","author":"Hodges","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0130","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.humpath.2007.08.005","article-title":"p16INK4 immunoreactivity is a reliable marker for urothelial carcinoma in situ","volume":"39","author":"Yin","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3892\/or.2010.1083","article-title":"Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study","volume":"25","author":"Cai","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2013.06.011_bb0140","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/infdis\/jir248","article-title":"Human papillomavirus infection and bladder cancer risk: a meta-analysis","volume":"204","author":"Li","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.humpath.2013.06.011_bb0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/bjc.2011.519","article-title":"Urinary human polyomavirus and papillomavirus infection and bladder cancer risk","volume":"106","author":"Polesel","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2013.06.011_bb0150","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00000478-199612000-00007","article-title":"Papillary urothelial hyperplasia. A precursor to papillary neoplasms","volume":"20","author":"Taylor","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0155","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/1097-0215(20001120)89:6<514::AID-IJC8>3.0.CO;2-H","article-title":"Papillary urothelial hyperplasia is a clonal precursor to papillary transitional cell bladder cancer","volume":"89","author":"Chow","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2013.06.011_bb0160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/00313021003767322","article-title":"Papillary urothelial hyperplasia: relationship to urothelial neoplasms","volume":"42","author":"Readal","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2013.06.011_bb0165","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00000478-200407000-00010","article-title":"Radiation or chemotherapy cystitis with \u201cpseudocarcinomatous\u201d features","volume":"28","author":"Chan","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/PAS.0b013e3180eaa1dc","article-title":"Pseudocarcinomatous epithelial hyperplasia in the bladder unassociated with prior irradiation or chemotherapy","volume":"32","author":"Lane","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0175","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.juro.2012.12.005","article-title":"Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients","volume":"189","author":"Kryvenko","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2013.06.011_bb0180","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1038\/sj.bjc.6603784","article-title":"Mcm2 predicts recurrence hazard in stage Ta\/T1 bladder cancer more accurately than CK20, Ki67 and histological grade","volume":"96","author":"Burger","year":"2007","journal-title":"Br J Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713002657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713002657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T19:31:41Z","timestamp":1646508701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713002657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0046817713002657"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.06.011","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}